Publications
REFEREED ARTICLES
1. Zehr KJ, Herskowitz A, Lee PC, Poston RS, Gillinov AM, Baumgartner WA. Neutrophil adhesion inhibition prolongs survival of cardiac allografts with hyperacute rejection. J Heart Lung Transplant 1993;12:837-845.
2. Zehr KJ, Lee PC, Poston RS, Gillinov AM, Hruban RH, Cameron DE. Protection of the internal mammary artery pedicle with polytetrafluoroethylene membrane. J Cardiac Surg 1993;8:650-655.
3. Zehr KJ, Herskowitz A, Lee PC, Kumar P, Gillinov AM, Baumgartner WA. Neutrophil adhesion and complement inhibition prolongs survival of cardiac xenografts in discordant species. Transplantation 1994;57:900-906.
4. Zehr KJ, Lee PC, Poston RS, Gillinov AM, Greene PS, Cameron DE. Two decades of coronary artery bypass graft surgery in young adults. Circulation 1994;90:II133-139.
5. Zehr KJ, Poston RS, Lee PC, Uthoff K, Kumar P, Cho PW, Gillinov AM, Redmond JM, Winkelstein JA, Herskowitz A. Platelet activating factor inhibition reduces lung injury after cardiopulmonary bypass. Ann Thorac Surg 1995;59:328-335.
6. Uthoff K, Zehr KJ, Lee PC, Low RA, Baumgartner WA, Cameron DE, Stuart RS. Neutrophil modulation results in improved pulmonary function after 12 and 24 hours of preservation. Ann Thorac Surg 1995;59:7-13.
7. Lee PC, Salyapongse AN, Bragdon GA, Shears LL, Watkins SC, Edington HDJ, Billiar TR. Impaired wound healing and angiogenesis in eNOS-deficient mice. Am J Physiol 1999;277:H1600-1608.
8. Lee PC, Rhee RY, Gordon RY, Fung JJ, Webster MW. Management of splenic artery aneurysms: the significance of portal and essential hypertension. J Am Coll Surg 1999;189:483-490.
9. Lee PC, Kibbe MR, Stolz DB, Gleixner SL, Watkins SC, Griffith BP, Billiar TR, Shears LL. Nitric oxide mediates growth factor-stimulated angiogenesis. Surgical Forum 1999;50:469-471.
10. Lee PC, Wang ZL, Qian S, Watkins SC, Lizonova A, Kovesdi I, Tzeng E, Simmons RL, Billiar TR, Shears LL. Endothelial nitric oxide synthase protects aortic allografts from the development of transplant arteriosclerosis. Transplantation 2000;69:1186-1192.
11. Kanno S*, Lee PC*, Zhang Y, Ho C, Griffith BP, Shears LL, Billiar TR. Attenuation of myocardial ischemia/reperfusion injury by superinduction of inducible nitric oxide synthase. Circulation 2000;101:2742-2748. * Shared co-authorship.
12. Lee PC, Wang ZL, Mahidhara R, Qian S, Watkins SC, Griffith BP, Billiar TR, Shears LL. Inducible nitric oxide synthase attenuates acute cardiac rejection. Surgical Forum 2000;51:357-359.
13. Lee PC, Kibbe MR, Schuchert MJ, Stolz DB, Watkins SC, Griffith BP, Billiar TR, Shears LL. Nitric oxide induces angiogenesis and upregulates v3 integrin expression on endothelial cells. Microvascular Research 2000;60:269-280.
14. Kanno S, Lee PC, Dodd SJ, Williams M, Griffith BP, Ho C. A novel approach with magnetic resonance imaging used for the detection of lung allograft rejection. J Thorac Cardiovasc Surg 2000;120:923-934.
15. Lee PC, Mateo RB, Clarke MR, Brown ML, Carty SE. Parathyromatosis: a cause for recurrent hyperparathyroidism. Endocrine Practice 2001;7:189-192.
16. Vorp DA, Lee PC, Wang DHJ, Makaroun MS, Nemoto EM, Ogawa S, Webster MW. Association of intraluminal thrombus in abdominal aortic aneurysm with local hypoxia and wall weakening. J Vasc Surg 2001;34:291-299.
17. Kanno S, Wu YL, Lee PC, Dodd SJ, Williams M, Griffith BP, Ho C. Macrophage accumulation associated with rat cardiac allograft rejection detected by magnetic resonance imaging with ultrasmall superparamagnetic iron oxide particles. Circulation 2001;104:934-938.
18. Kanno S, Wu YL, Lee PC, Billiar TR, Ho C. Angiotensin-converting enzyme inhibitor preserves p21 and endothelial nitric oxide synthase expressions in Monocrotaline-induced pulmonary arterial hypertension in rats. Circulation 2001;104:945-950.
19. Port JL, Kent M, Korst RJ, Lee PC, Levin MA, Flieder D, Altorki NK.
Surgical resection for lung cancer in the octogenarian. Chest 2004; 126(3):733-8.
20. Korst RJ, Gold HT, Kent MS, Port JL, Lee PC, Altorki NK. Surveillance computed tomography after complete resection for non-small cell lung cancer: results and costs. Journal of Thoracic & 5Cardiovascular Surgery 2005;129:652-60.
21. Port JL, Korst RJ, Lee PC, Levin MA, Becker DE, Keresztes R, Altorki NK. Surgical resection for residual N2 disease after induction chemotherapy. Ann Thorac Surg 2005; 79:1686-1690.
22. Korst RJ, Port JL, Lee PC, Altorki NK. Intrathoracic manifestations of cervical anastomotic leaks after transthoracic esophagectomy for carcinoma. Ann Thorac Surg 2005; 80:1185-90.
23. Kent MS, Korn P, Port JL, Lee PC, Altorki NK, Korst RJ. Cost effectiveness of chest computed tomography after lung cancer resection: a decision analysis model. Ann Thorac Surg 2005; 80:1215-23.
24. Port JL, Andrade RS, Levin MA, Korst RJ, Lee PC, Becker DE, Altorki NK. Positron emission tomographic scanning in the diagnosis and staging of non-small cell lung cancer 2 cm in size or less. J Thorac Cardiovasc Surg 2005; 130:1611-5.
25. Korst RJ, Kansler AL, Port JL, Lee PC, Karem Y, Altorki NK. Downstaging of T or N predicts long-term survival after preoperative chemotherapy and radical resection for esophageal carcinoma. Ann Thorac Surg 2006; 82:480-4.
26. Korst RJ, Kansler AL, Port JL, Lee PC, Altorki NK. Accuracy of surveillance computed tomography in detecting recurrent or new primary lung cancer in patients with completely resected lung cancer. Ann Thorac Surg 2006; 82:1009-15.
27. Lee PC, Korst RJ, Port JL, Kerem Y, Kansler A, Altorki NK. Long-term survival and recurrence in patients with resected non-small cell lung cancer 1 cm or less in size. J Thorac Cardiovasc Surg 2006;132(6):1382-88.
28. Kreisel D, Arora N, Weisenberg SA, Saqi A, Krupnick AS, MDa, Demetriades AM, Iakovou C, Conetta R, Lee PC. Tuberculosis presenting as an endobronchial mass. J Thorac Cardiovasc Surg 2007; 133:582-584.
29. Port JL, Korst RJ, Lee PC, Kansler AL, Kerem Y, Altorki NK. Surgical resection for multifocal (T4) non-small cell lung cancer: Is the T4 designation valid? Ann Thorac Surg 2007; 83:397-401.
30. Kim AW, Korst RJ, Port JL, Altorki NK, Lee PC. Giant cavernous hemangioma of the distal esophagus treated with esophagectomy. J Thorac Cardiovasc Surg 2007; 133: 1665 - 1667.
31. Lee PC, Port JL, Korst RJ, Liss Y, Meherally DN, Altork NK. Risk factors for occult mediastinal metastases in clinical stage I non-small cell lung cancer. Ann Thorac Surg 2007; 84:177-181.
32. Robinson DA, Lee, PC. Middle lobe syndrome: Case report and review of literature. Clin Pulm Med 2007; 14:244-248.
33. Port JL, Lee PC, Korst RJ, Liss Y, Meherally D, Christos P, Mazumdar M, and Altorki NK. Positron emission tomographic scanning predicts survival after induction chemotherapy for esophageal carcinoma. Ann Thorac Surg 2007; 84:393-400.
34. Huston JM, King H, Maresh A, Liska D, Port JL, Altorki NK, Lee PC. Hernia of Morgagni: case report. J Thorac Cardiovasc Surg 2008; 135(1):212-3.
35. Sica G, Vazquez MF, Altorki N, Port J, Lee PC, Liu Y, Hyjek E, Saqi A. PAX-5 expression in pulmonary neuroendocrine neoplasms: Its usefulness in surgical and fine-needle aspiration biopsy specimens. Am J Clin Pathol. 2008; 129(4):556-62.
36. Wagner PL, Tam W, Lau PY, Port JL, Paul S, Altorki NK, Lee PC. Primary esophageal large T-cell lymphoma mimicking esophageal carcinoma: A case report and literature review. J Thorac Cardiovasc Surg 2008; 135:957-8.
37. Altorki NK, Lee PC, Liss Y, Meherally D, Korst RJ, Christos P, Mazumdar M, Port JL. Multifocal neoplasia and nodal metastases in T1 esophageal carcinoma: implications for endoscopic treatment. Ann Surg 2008; 247(3):434-9.
38. Servais E, Paul S, Port JL, Altorki NK, Lee PC. Carcinoid tumor nested within a bronchogenic cyst. J Thorac Cardiovasc Surg 2008; 136(1):227-8.
39. Altorki NK, Zhou XK, Stiles B, Port JL, Paul S, Lee PC, Mazumdar M. Total number of resected lymph nodes predicts survival in esophageal cancer. Ann Surg 2008; 248(2):221-6.
40. Sharma B, Agarwal S, Karbowitz S, Gumpeni R, Lee PC, Paul S. A man with end-stage renal disease and dyspnea. Journal of Respiratory Diseases 2008; 29(8):302-306.
41. Abrams JA, Lee PC, Port JL, Altorki NK, Neuqut AI. Cigarette smoking and risk of lung metastasis from esophageal cancer. Cancer Epidemiol Biomarkers Prev 2008;17(10):2707-13.
42. John BK, Luo JJ, Lee PC, Fleming RA. Choriocarcinoma: an unusual cause of hemoptysis. Journal of Respiratory Diseases 2008; 29(10):376-381.
43. Bhavneesh S, Sha K, Lee PC. A 75-year-old man with significant bleeding after transbronchial biopsy. Platelets 2008;19(7): 559-560.
44. Agarwal S, Sharma B, Sabayev V, Lee PC, Gumpeni R. Primary synovial sarcoma presenting as an endobronchial mass. Journal of Respiratory Diseases 2008; 29(11):435-437.
45. Sica G, Wagner PL, Altorki N, Port J, Lee PC, Vazquez MF, Saqi A. Immunohistochemical expression of estrogen and progesterone receptors in primary pulmonary neuroendocrine tumors. Arch Pathol Lab Med. 2008;132(12):1889-95.
46. Bijo K, Luo JJ, Lee PC, Fleming RA. Choriocarcinoma: an unusual case of hemoptysis. (A Case in Point). J Resp Diseases. 2008;(29)10:376.
47. Stiles BM, Servais EL, Lee PC, Port JL, Paul S, Altorki NK. Clinical stage IA non-small cell lung cancer determined by computed tomography and positron emission tomography is frequently not pathologic IA non-small cell lung cancer: The problem of understaging. J Thorac Cardiovasc Surg 2009;137:13-9.
48. Paul S, Lee, PC, Altorki NK, Stiles BM, Port JL. Partial upper sternotomy for
anterosuperior mediastinal surgery: An institutional experience. Ann Surg Oncol 2009; 16(4) 1039-42.
49. Wagner PL, Hyjek E, Vazquez MF, Meherally D, Liu YF, Chadwick PA, Rengifo T, Sica GL, Port JL, Lee PC, Paul S, Altorki NK, Saqi A. CXCL12 and CXCR4 in adenocarcinoma of the lung: association with metastasis and survival. J Thorac Cardiovasc Surg 2009;137(3):615-21.
CHAPTERS & REVIEW ARTICLES
1. Lee PC, Shears LL, Billiar TR. Role of inducible nitric oxide synthase in transplant arteriosclerosis. Clin Exp Pharmacol Physiol 1999;26:1013-1015.
2. Kibbe MR*, Lee PC*, Billiar TR, Tzeng E. Nitric oxide synthase gene transfer. In: Ignarro LJ, editor. Nitric oxide: Biology and pathobiology. 1st ed. Academic Press 2000:503-524.
3. Lee PC, Altorki NK. Surgery Techniques – en-bloc Esophagectomy. In: Esophageal Tumors: Principles and Practice. Jobe PA, Thomas CR, Hunter JG. Demos Medical Publishing; 2008. Submitted.
4. Altorki NK, Zhou K, Stiles B, Port JL, Paul S, Lee PC, Mazumdar M. Extended Resection for Esophageal Carcinoma. In: Shields TW, ed. General Thoracic Surgery, 7th edition. Lippincott Williams & Wilkins, 2008. In Press.
* Shared co-authorship.
PUBLISHED ABSTRACTS
1. Lee PC, Billiar TR, Watkins SC, Griffith BP, Shears LL. Endothelial nitric oxide synthase (eNOS) is not required for vascular endothelial growth factor (VEGF) induced angiogenesis. FASEB Journal 1999;13:A1007.
2. Lee PC, Rhee RY, Gordon RY, Webster MW, Fung JJ. Management of splenic artery aneurysms (SAA) in liver transplant patients. Liver Transplantation and Surgery 1999;5:C41.
3. Lee PC, Kibbe MR, Schuchert MJ, Stolz DB, Gleixner SL, Watkins SC, Griffith BP, Billiar TR, Shears LL. Nitric oxide induces angiogenesis by upregulation of vitronectin expression in endothelial cells. Circulation, Suppl 1999;100:I405.
4. Kanno S, Zhang Y, Ho C, Shears LL, Griffith BP, Billiar TR, Lee PC. The effects of nitric oxide on myocardial ischemia reperfusion injury in mice. Circulation, Suppl 1999;100:I112.
5. Lee PC, Wang ZL, Watkins SC, Qian S, Billiar TR, Shears LL. Endothelial nitric oxide synthase protects allografts from transplant vasculopathy. J Surg Research 1999;86:279.
6. Lee PC, Billiar TR, Watkins SC, Griffith BP, Shears LL. Endothelial nitric oxide synthase (eNOS) is not required for basic fibroblast growth factor (bFGF) induced angiogenesis in vivo. Journal of Vascular and Interventional Radiology 1999;10(7):987.
7. Lee PC, Wang ZL, Mahidhara R, Qian S, Watkins SC, Griffith BP, Billiar TR, Shears LL. Inducible nitric oxide synthase attenuates acute cardiac rejection. J Am Coll Surg 2000;191 (No.4 Suppl):S98-S99.
8. Wang ZL, Zhang Y, Hu T, Billiar TR, Lee PC. Myocardial assessment by MRI in murine heterotopic heart transplant models. FASEB Journal 2001;15:A1007.
9. Altorki N, Guarino M, Lee P, Pass HI, Filip E, Bauer T, Roychowdhury D, Zaks T, Ottesen L, Yankelevitz D. Preoperative treatment with pazopanib (GW786034), a multikinase angiogenesis inhibitor in early-stage non-small cell lung cancer (NSCLC): A proof-of-concept phase II study. Journal of Clinical Oncology 2008;26(15Suppl Part I):411s.
10. Sharma BK, Reddy M, Lee PC, Gumpeni R. An interesting presentation of a rare renal tumor. Chest Meeting Abstracts 2008;134:C27001.
11. Salehmohamed MA, Reddy K, Lee PC, Gumpeni R. Peripheral arterial tumor emboli from lung cancer. Chest Meeting Abstracts 2008; 134:C39001.
PRESENTATIONS
1. Lee PC, Rhee RY, Gordon RY, Fung JJ, Webster MW. The changing face of splenic artery aneurysms (SAA): the significance of portal and essential hypertension. Peripheral Vascular Surgery Society, Ninth Annual Winter Meeting. Snowbird, Utah, January 1999.
2. Lee PC, Rhee RY, Gordon RY, Fung JJ, Webster MW. The significance of portal and essential hypertension in splenic artery aneurysms (SAA): the UPMC experience. Pittsburgh Surgical Society, Five Most Interesting Cases of 1998. Pittsburgh, Pennsylvania, January 1999.
3. Lee PC, DeRenzo J, Watkins SC, Griffith BP, Billiar TR, Shears LL. Endothelial nitric oxide synthase (eNOS) is essential for angiogenesis. Oral and poster presentations at the Keystone Symposia conference on Inflammatory Paradigms and the Vasculature. Santa Fe, New Mexico, February 1999.
4. Lee PC, Billiar TR, Watkins SC, Griffith BP, Shears LL. Endothelial nitric oxide synthase (eNOS) is not required for basic fibroblast growth factor (bFGF) induced angiogenesis in vivo. Poster presentation at the Lifeline Foundation Research Initiatives in Vascular Disease Conference. Bethesda, Maryland, March 1999.
5. Lee PC, Kibbe MR, Stolz DB, Gleixner SL, Watkins SC, Griffith BP, Billiar TR, Shears LL. Nitric oxide mediates growth factor-stimulated angiogenesis in vitro and in vivo. Poster presentation at the American Heart Association Western PA District 7th Annual Fellows’ Research Day. First Place Winner. Pittsburgh, Pennsylvania, March 1999.
6. Lee PC, Billiar TR, Watkins SC, Griffith BP, Shears LL. Endothelial nitric oxide synthase (eNOS) is not required for vascular endothelial growth factor (VEGF) induced angiogenesis. Experimental Biology ’99 (FASEB). Washington, DC, April 1999.
7. Lee PC, Rhee RY, Gordon RY, Webster MW, Fung JJ. Management of splenic artery aneurysms (SAA) in liver transplant patients. Poster presentation at the International Liver Transplantation Society, Fifth Congress. Pittsburgh, Pennsylvania, August 1999.
8. Lee PC, Kibbe MR, Stolz DB, Gleixner SL, Watkins SC, Griffith BP, Billiar TR, Shears LL. Nitric oxide mediates growth factor-stimulated angiogenesis. American College of Surgeons, 85th Annual Clinical Congress. San Francisco, California, October 1999.
9. Lee PC, Kibbe MR, Schuchert MJ, Stolz DB, Gleixner SL, Watkins SC, Griffith BP, Billiar TR, Shears LL. Nitric oxide induces angiogenesis by upregulation of vitronectin expression in endothelial cells. Poster presentation at the American Heart Association, 72nd Scientific Sessions. Atlanta, Georgia, November 1999.
10. Kanno S, Zhang Y, Ho C, Shears LL, Griffith BP, Billiar TR, Lee PC. The effects of nitric oxide on myocardial ischemia reperfusion injury in mice. Poster presentation at the American Heart Association, 72nd Scientific Sessions. Atlanta, Georgia, November 1999.
11. Lee PC, Wang ZL, Watkins SC, Qian S, Billiar TR, Shears LL. Endothelial nitric oxide synthase protects allografts from transplant vasculopathy. Association for Academic Surgery, 33rd Annual Meeting. Philadelphia, Pennsylvania, November 1999.
12. Lee PC, Kibbe MR, Schuchert MJ, Stolz DB, Green AM, Watkins SC, Griffith BP, Billiar TR, Shears LL. Nitric oxide induces angiogenesis and upregulates v3 integrin expression on endothelial cells. The Southern Association for Vascular Surgery, 24th Annual Meeting. Tucson, Arizona, January 2000.
13. Lee PC, Kibbe MR, Green AM, Schuchert MJ, Watkins SC, Griffith BP, Billiar TR, Shears LL. Nitric oxide stimulation of angiogenesis is associated with suppressed PECAM-1 expression. The Society of University Surgeons, 42nd Annual University Surgical Residents’ Conference. Toronto, Canada, February 2000.
14. Lee PC, Kibbe MR, Green AM, Schuchert MJ, Griffith BP, Billiar TR, Shears LL. Nitric oxide stimulation of angiogenesis is associated with suppressed PECAM-1 expression. Poster presentation at the Keystone Symposia conference on Experimental and Clinical Regulation of Angiogenesis. Salt Lake City, Utah, March 2000.
15. Vorp DA, Lee PC, Wang DHJ, Makaroun MS, Ogawa S, Billiar TR, Webster MW. Association of intraluminal thrombus in abdominal aortic aneurysm with local hypoxia, inflammation, neovascularization and wall weakening. International Society of Applied Cardiovascular Biology, 7th Biennial Meeting. Tucson, Arizona, March 2000.
16. Lee PC, Wang ZL, Qian S, Mahidhara R, Watkins SC, Griffith BP, Billiar TR, Shears LL. Inducible nitric oxide synthase attenuates acute cardiac allograft rejection. American Heart Association Western PA District 8th Annual Fellows’ Research Day. Pittsburgh, Pennsylvania, March 2000.
17. Lee PC, Wang ZL, Watkins SC, Qian S, Billiar TR, Shears LL. Endothelial nitric oxide synthase protects allografts from transplant vasculopathy. Poster presentation at the Southwestern Pennsylvania Chapter of the American College of Surgeons, 46th Annual Meeting and Residents’ Day. Pittsburgh, Pennsylvania, March 2000.
18. Kanno S, Lee PC, Zhang Y, Dodd S, Williams M, Williams DS, Billiar TR, Griffith BP, Ho C. A novel approach using magnetic resonance technique for the detection of lung allograft rejection. American Association for Thoracic Surgery, 80th Annual Meeting. Toronto, Canada, May 2000.
19. Lee PC, Wang ZL, Mahidhara R, Qian S, Watkins SC, Griffith BP, Billiar TR, Shears LL. Inducible nitric oxide synthase attenuates acute cardiac rejection. American College of Surgeons, 86th Annual Clinical Congress. Chicago, Illinois, October 2000.
20. Kanno S, Wu YL, Lee PC, Ho C. ACE-Inhibitor preserves p21 and eNOS expressions in Monocrotaline-induced pulmonary hypertensive rats. Poster presentation at the American Heart Association, 73rd Scientific Sessions. New Orleans, Georgia, November 2000.
21. Wang ZL, Zhang Y, Hu T, Billiar TR, Lee PC. Myocardial assessment by MRI in murine heterotopic heart transplant models. Poster presentation at Experimental Biology 2001 (FASEB). Orlando, Florida, April 2001.
22. Lee PC, Brodman RF, Choudhry MS, Cartledge RG. Initial experience with ulnar artery use for coronary artery bypass grafting. New York Society for Thoracic Surgery. New York, New York, November 2001.
23. Korst RJ, Port JL, Lee PC and Altorki NK. The Utility of Postoperative Surveillance CT scans in Patients with Completely Resected Non-small Cell Lung Cancer. Presented at the New York Chapter of The Society of Thoracic Surgeons Fall Scientific Meeting, October, 2003.
24. Port JL, Korst RJ, Lee PC, Levin MA, Altorki NK. Residual N2 Disease Following Neoadjuvant Chemotherapy For Non-small Cell Lung Cancer (NSCLC) Does Not Preclude Long-term Survival. Presentation at the 40th Annual Meeting of the Society of Thoracic Surgeons, San Antonio, TX. January 2004.
25. Korst RJ, Port JL, Lee PC and Altorki NK. The Utility of Postoperative Surveillance CT scans in Patients with Completely Resected Non-small Cell Lung Cancer. Presented at the New York Chapter of The Society of Thoracic Surgeons Fall Scientific Meeting, 2004.
26. Korst RJ, Gold HT, Port JL, Lee PC, Altorki NK. Surveillance CT Scans Following Complete Resection for Non-small Cell Lung Cancer: Analysis of Results and Costs. Presented at the 84th Annual Meeting of The American Association for Thoracic Surgery, Toronto, Canada. April 26, 2004.
27. Kent MS, Korn P, Port JL, Lee PC, Altorki NK, Korst RJ. Cost-effectiveness of Surveillance Computed Tomography Following Resection of Stage IA Non-small Cell Lung Cancer: A Decision Analysis Model. Presented at The 41st Annual Meeting of The Society of Thoracic Surgeons, Tampa, FL, January 25, 2005.
28. Port JL, Becker D, Korst RJ, Lee PC, Altorki NK. Surgical Resection for Multifocal (T4 or M1) NSCLC: Are the T4 and M1 designations valid? Proceedings of the 41st Annual Meeting of The American Society of Clinical Oncology, May, 2005.
29. Lee PC, Korst RJ, Port JL, Becker DE, Kerem Y, Kansler A, Altorki NK. Long-term Survival and Recurrence in Patients with Resected Subcentimeter Non-small Cell Lung Cancer. Presented at the 86th Annual Meeting of The American Association for Thoracic Surgery, Philadelphia, PA. May 1, 2006.
30. Lee PC, Port JL, Korst RJ, Kansler A, Kerem Y, Liss Y, Altorki NK. Risk Factors for Occult Mediastinal Metastase in Clinical Stage I Non-Small Cell Lung Cancer Screened by Computerized Tomography and Positron Emission Tomography. Poster presented at The 43rd Annual Meeting of The Society of Thoracic Surgeons, San Diego, CA, January, 2007.
31. Korst RJ, Port JL, Lee PC, Altorki NK. Antigen-specific CD8 cell responses in patients with esophageal carcinoma. Presented at the 87th Annual Meeting of The American Association for Thoracic Surgery, Washington, DC. May, 2007.
32. Jin D, Port JL, Korst R, Lee P, Zhang L, McDonald KA, Ferrara CA, Meherally D, Rafii S, Altorki NK. Surgical resection normalizes the hemangiogenic profile in patients with non-small cell lung cancer. Presented at the 87th Annual Meeting of The American Association for Thoracic Surgery, Washington, DC. May, 2007.
33. Altorki NK, Port JL, Lee PC, Liss Y, Meherally D, Jin D, Korst RJ. Multifocal neoplasia in T1 esophageal carcinoma: Implications for endoscopic treatment. Presented at the 87th Annual Meeting of The American Association for Thoracic Surgery, Washington, DC. May, 2007.
34. Singhal S, Gumpeni R, Lee P. Impact of pulmonary function test in VATS-assisted lung resections: Community hospital experience. Poster presented at the American Thoracic Society, San Francisco, CA, May, 2007.
35. Singhal S, Gumpeni R, Lee P. Impact of pulmonary function test in VATS-assisted lung resections: Community hospital experience. Presented at the Residents and Fellows Day, New York Hospital Queens, Flushing, NY, May, 2007.
36. Stiles BM, Lee PC, Servais EL, Port JL, Paul S, Meherally D, Altorki NK. Clinical stage IA lung cancer by CT and PET Scan: The persistent problem of understaging. Presented at the American Association for Thoracic Surgery Annual Meeting, San Diego, CA, May 12, 2008.
37. Wagner PL, Vazquez M, Port J, Lee P, Saqi A, Altorki N. Association with survival of the CXCL12-CXCR4 chemokine axis in adenocarcinoma of the lung. Presented at the American Association for Thoracic Surgery Annual Meeting, San Diego, CA, May 13, 2008.
38. Altorki N, Guarino M, Lee P, Pass HI, Filip E, Bauer T, Roychowdhury D, Zaks T, Ottesen L, Yankelevitz D. Preoperative treatment with pazopanib (GW786034), a multikinase angiogenesis inhibitor in early-stage non-small cell lung cancer (NSCLC): A proof-of-concept phase II study. Poster presented at the American Society of Clinical Oncolocy (ASCO) Annual Meeting, Chicago, IL, June 1, 2008.
39. Altorki N, Heymach JV, Guarino MJ, Lee P, Filip E, Bauer T, Pass H, Swann S, Ottesen LH, Yankelevitz D. Phase II study of pazopanib (GW786034) given preoperatively in Stage I-II non-small cell lung cancer (NSCLC): a proof-of-concept study. Poster presented at the 1st International Thoracic Oncology Congress. Dresden, Germany, October, 2008.
40. Lee PC, Port J, Paul S, Stiles BM, Meherally, Altorki NK. Predictors of long-term survival following resection of esophageal carcinoma with non-regoinal (M1a) nodal metastases. Presented at the society of Thoracic Surgeons Annual Meeting, San Francisco, CA, January 27, 2009.
INVITED LECTURES
1. Current surgical management of lung cancer. New York Hospital Queens. Pulmonary Grand Rounds. New York, New York, June 2003.
2. Current management of lung cancer. New York Hospital Queens. Medical Grand Rounds. New York, New York, September 2003.
3. Lung cancer. New York Queens Nan Shan Senior Citizen Center. New York, New York, December 2003.
4. Lung cancer. Live radio (1480AM) interview. New York, New York, January 2004.
5. Advances in thoracoscopic surgery. New York Hospital Queens. Medical Grand Rounds. New York, New York, January 2004.
6. Surgical management of achalasia. New York Hospital Queens. Gastroenterology Grand Rounds. New York, New York, January 2004.
7. Current management of esophageal cancer. Chinese American Medical Society Annual Scientific Meeting. New York, New York, October 2004.
8. Current directions in the screening and management of lung cancer. First New York Hospital Queens Lung Cancer Symposium. Program co-chair. Lecture: Current surgical staging and management of lung cancer. Flushing, New York, October 2004.
9. Diagnosis and treatment of lung cancer. Live radio (1480AM) interview. New York, New York, November 2004.
10. Current management of esophageal cancer. New York Hospital Queens. Medical Grand Rounds. New York, New York, November 2004.
11. Advances in thoracoscopic surgery. Annual Clinic Day. The Nassau Surgical Society and Brooklyn & Long Island Chapter of the American College of Surgeons. Long Island, New York, December 2004.
12. Current surgical management of benign esophageal diseases. New York Hospital Queens. Medical Grand Rounds. New York, New York, September 2005.
13. Advances in diagnosis and treatment of early stage lung cancer. Second New York Hospital Queens Lung Cancer Symposium. Program co-chair. Lecture: Surgical staging and management of early stage lung cancer. Flushing, New York, October 2005.
14. Current directions in screening and management of early stage lung cancer. Third New York Hospital Queens Lung Cancer Symposium. Program co-chair. Lecture: Advances in surgical staging and management of early stage non-small cell lung cancer. Flushing, New York, November 2006.
15. Diagnosis and treatment of lung cancer. Live radio (1480AM) interview. New York, New York, November 2006.
16. A surgeon’s view of the behavior of early non-small cell lung cancer. Small lung nodules: management in patients at risk for lung cancer and technique of radiotracer guided thoracoscopic excisional biopsy of lung nodules. Course sponsored by the University of Virginia departments of surgery and radiology. Charlottesville, Virginia, February 2007.
17. Lung cancer screening – where do we stand in 2007? 1st Annual Cancer Teaching Day, “Common problems in common malignancies.” Co-sponsored by Saint Francis Hospital, Dutchess County Medical Society, and American Cancer Society. Poughkeepsie, New York, May 2007.
18. Current management of esophageal cancer. Methodist Hospital. General Surgery Grand Rounds. Brooklyn, New York, October 2007.
19. Advances in diagnosis and treatment of mediastinal, chest wall and pleural tumors. Fourth New York Hospital Queens Thoracic Oncology Symposium. Program co-chair. Lecture: Diagnosis and management of mediastinal tumors. Flushing, New York, November 2007.
20. Thoracoscopic lobectomy with mediastinal lymph node dissection. Advances in thoracoscopic surgery. XVII International Congress of Endoscopic Surgery. Puerto Vallarta, Mexico, May 2008.
21. Current management of non-small cell lung cancer. New York Downtown Hospital. Surgical Grand Rounds. New York, New York, May 2008.
22. Diagnosis and treatment of esophageal cancer. Live radio (1480AM) interview. New York, New York, November 2008.
23. Advances in diagnosis and treatment of lung and esophageal cancer. Fifth New York Hospital Queens Thoracic Oncology Symposium. Program co-chair. Lecture: Role of esophagectomy for esophageal cancer. Flushing, New York, November 2008.
24. Current management of non-small cell lung cancer. New York Downtown Hospital. Medical Grand Rounds. New York, New York, March 2009.
